Form4.ai tracks every SEC insider trade in real time. See every ADRX insider filing with a free account — no card.
See every ADRX insider filing — free account, no card.
Free accountADARx Pharmaceuticals, Inc. (ADRX) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $87.7M. Most recent filing: Sept. 30, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 30, 2026 SEC filing | Chimovits Erez Director | Bought | $1,045,772 | +6.7% 30D |
| Sep 30, 2026 SEC filing | GORDON CARL L Director Same trade as ORBIMED ADVISORS LLC | Bought | $16,150,000 | +6.7% 30D |
| Sep 29, 2026 SEC filing | SR ONE CAPITAL MANAGEMENT, LLC 10% Owner Same trade as George Simeon | Bought | $27,200,000 | +6.7% 30D |
Create a free account to see all 11 ADRX filings from the last 90 days. No card needed.
Create free accountWant ADRX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.